MDQK.HM up 200.00% to €7.50 on 05 Jan 2026: oversold bounce merits close technical watch
The MDQK.HM stock jumped 200.00% to €7.50 in morning trade on 05 Jan 2026, an intraday move that fits an oversold bounce pattern during market hours on HAM (Germany). The spike followed an open at €2.50 and a day low of €2.50, but volume stayed thin at 35 shares, highlighting a fragile rally. For tactical traders this is a short-term rebound opportunity; for longer-term investors the lack of EPS, low liquidity and mixed fundamentals require caution.
Intraday price action and liquidity
MDQK.HM climbed from an open of €2.50 to a day high and current price of €7.50, a €5.00 change representing 200.00% on 05 Jan 2026 during HAM market hours. Volume is just 35 shares versus an average volume of 41, which shows the move is driven by very low liquidity. Thin trading increases volatility and raises the chance of sharp retracements after this oversold bounce.
Why this qualifies as an oversold bounce
The price jump follows an extended weakness to a year low of €1.50 and fast mean reversion: 50-day average is €2.50 and 200-day average is €2.00. Those averages sit well below the current €7.50, a classic setup where sellers were exhausted and a bounce can produce large percentage moves. However the technical picture is incomplete: RSI shows 0.00 in the available feed and ATR is €5.00, underlining extreme intraday volatility rather than a steady recovery.
Fundamental snapshot
MediNavi AG (MDQK.HM) operates a patient-doctor matching and second-opinion platform based in Munich, Germany. There is no reported EPS or PE ratio. Enterprise value (TTM) is -€255,031.00 and enterprise-value-to-EBITDA is 2.17. Balance-sheet metrics show a current ratio of 41.50 and working capital of €269,922.60. Return on equity is -6.60% and interest coverage is -1,362.59, reflecting negative operating profitability despite a cash cushion.
Technical levels and realistic price targets
Near-term support is the open and previous close at €2.50 and the day low of €2.50. Immediate resistance is current consolidation around the year high of €7.50. For scenario planning we set tactical price targets: Bear €2.00 (-73.33% from €7.50), Base €9.00 (+20.00%), Bull €12.00 (+60.00%). These are model-based guideposts; stop-losses are recommended given the 50-day average of €2.50 and limited liquidity.
Sector context and catalysts
MDQK.HM trades in Healthcare, Medical – Healthcare Information Services. The broader healthcare sector has been flat to negative YTD (-3.25%) and 1-year (-4.67%), which tempers optimism for a structural recovery. Near-term catalysts would be a corporate update, user growth metrics from www.medinavi.de, or clear revenue disclosures. Absent fresh fundamental news, price moves will likely remain led by flows and low-volume trades.
Meyka AI grading and analyst view
Meyka AI rates MDQK.HM with a score out of 100: 66.75 (Grade B — HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade reflects a tactical opportunity for short-term traders on an oversold bounce but a HOLD stance for longer-term investors due to limited fundamentals and liquidity risk.
Final Thoughts
MediNavi AG (MDQK.HM) delivered a sharp intraday oversold bounce to €7.50 on 05 Jan 2026, driven by a move from €2.50 and a €5.00 one-day change. The price action fits a tactical bounce setup but is undercut by very low volume (35 shares) and a lack of reported EPS or scheduled earnings. Traders can treat this as a short-term mean-reversion trade with tight risk control: use stops near the €2.50 pivot and scale exposure to reflect low liquidity. Meyka AI’s forecast model projects three scenario targets: Bear €2.00 (implied -73.33% vs current €7.50), Base €9.00 (implied +20.00%), Bull €12.00 (implied +60.00%). Forecasts are model-based projections and not guarantees. As an AI-powered market analysis platform, Meyka flags this as a high-volatility, high-risk setup suited to nimble traders rather than buy-and-hold investors. Monitor follow-up corporate news, intraday volume above the 41-share average, and any revenue or user metrics before expanding exposure.
FAQs
The 200.00% spike to €7.50 is an oversold bounce; it may offer short-term trade opportunities. Given no EPS, thin volume (35 shares), and limited fundamentals, Meyka rates it HOLD. Use tight stops and treat any position as speculative.
Key support is €2.50 (open, previous close and day low). Immediate resistance and consolidation sits at €7.50 (day and year high). The 50-day average is €2.50 and 200-day average is €2.00.
Meyka AI’s forecasts use historical, sector and liquidity data to project scenarios. They are model-based projections, not guarantees. For MDQK.HM we show Bear €2.00, Base €9.00, Bull €12.00; apply risk management and confirm with company updates.
Primary risks include extremely low liquidity, lack of reported EPS, limited public disclosure, and sector headwinds in healthcare. Volatility can produce fast gains or steep losses, so position sizing and stops are essential.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
